113 related articles for article (PubMed ID: 9503408)
1. [Development of KRN7000, derived from agelasphin produced by Okinawan sponge].
Natori T; Akimoto K; Motoki K; Koezuka Y; Higa T
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():63P-68P. PubMed ID: 9503408
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice.
Morita M; Motoki K; Akimoto K; Natori T; Sakai T; Sawa E; Yamaji K; Koezuka Y; Kobayashi E; Fukushima H
J Med Chem; 1995 Jun; 38(12):2176-87. PubMed ID: 7783149
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells.
Yamaguchi Y; Motoki K; Ueno H; Maeda K; Kobayashi E; Inoue H; Fukushima H; Koezuka Y
Oncol Res; 1996; 8(10-11):399-407. PubMed ID: 9114432
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4 - octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice.
Motoki K; Maeda K; Ueno H; Kobayashi E; Uchida T; Fukushima H; Koezuka Y
Oncol Res; 1996; 8(4):155-62. PubMed ID: 8869965
[TBL] [Abstract][Full Text] [Related]
5. KRN7000, a novel immunomodulator, and its antitumor activities.
Kobayashi E; Motoki K; Uchida T; Fukushima H; Koezuka Y
Oncol Res; 1995; 7(10-11):529-34. PubMed ID: 8866665
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of novel glycosphingolipids that stimulate natural killer T-cells.
Tashiro T
Biosci Biotechnol Biochem; 2012; 76(6):1055-67. PubMed ID: 22790924
[TBL] [Abstract][Full Text] [Related]
7. Practical Total Synthesis of (2S,3S,4R)-1-O-(α-D-Galactopyranosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, the Antitumorial and Immunostimulatory α-Galactosylcer-amide, KRN7000.
Morita M; Sawa E; Yamaji K; Sakai T; Natori T; Koezuka Y; Fukushima H; Akimoto K
Biosci Biotechnol Biochem; 1996 Jan; 60(2):288-92. PubMed ID: 27299402
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide).
Shiozaki M; Tashiro T; Koshino H; Shigeura T; Watarai H; Taniguchi M; Mori K
Carbohydr Res; 2013 Apr; 370():46-66. PubMed ID: 23454137
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production.
Nakagawa R; Motoki K; Nakamura H; Ueno H; Iijima R; Yamauchi A; Tsuyuki S; Inamoto T; Koezuka Y
Oncol Res; 1998; 10(11-12):561-8. PubMed ID: 10367937
[TBL] [Abstract][Full Text] [Related]
10. RCAI-61 and related 6'-modified analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce interferon-γ in vivo.
Tashiro T; Nakagawa R; Shigeura T; Watarai H; Taniguchi M; Mori K
Bioorg Med Chem; 2013 Jun; 21(11):3066-79. PubMed ID: 23602521
[TBL] [Abstract][Full Text] [Related]
11. Enhancing effects of agelasphin-11 on natural killer cell activities of normal and tumor-bearing mice.
Kobayashi E; Motoki K; Natori T; Uchida T; Fukushima H; Koezuka Y
Biol Pharm Bull; 1996 Mar; 19(3):350-3. PubMed ID: 8924898
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells.
Nakagawa R; Serizawa I; Motoki K; Sato M; Ueno H; Iijima R; Nakamura H; Shimosaka A; Koezuka Y
Oncol Res; 2000; 12(2):51-8. PubMed ID: 11132924
[TBL] [Abstract][Full Text] [Related]
13. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
[TBL] [Abstract][Full Text] [Related]
14. RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines.
Tashiro T; Hongo N; Nakagawa R; Seino K; Watarai H; Ishii Y; Taniguchi M; Mori K
Bioorg Med Chem; 2008 Oct; 16(19):8896-906. PubMed ID: 18790646
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
[TBL] [Abstract][Full Text] [Related]
16. Intramolecular nitrogen delivery for the synthesis of C-glycosphingolipids. Application to the C-glycoside of the immunostimulant KRN7000.
Altiti AS; Mootoo DR
Org Lett; 2014 Mar; 16(5):1466-9. PubMed ID: 24559301
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
[TBL] [Abstract][Full Text] [Related]
18. A new screening method for antimitotic substances and isolation of glycolipids as stimulators of tubulin polymerization from Okinawan sponge Pseudoceratina sp.
Meguro S; Namikoshi M; Kobayashi H
J Antibiot (Tokyo); 2002 Mar; 55(3):256-62. PubMed ID: 12014440
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells.
Van Der Vliet HJ; Nishi N; Koezuka Y; Peyrat MA; Von Blomberg BM; Van Den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
Immunology; 1999 Dec; 98(4):557-63. PubMed ID: 10594688
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH.
Ndonye RM; Izmirian DP; Dunn MF; Yu KO; Porcelli SA; Khurana A; Kronenberg M; Richardson SK; Howell AR
J Org Chem; 2005 Dec; 70(25):10260-70. PubMed ID: 16323834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
